Thousands of NHS patients denied breakthrough Alzheimer’s drugs

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has said
What's Your Reaction?







Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has said
Jun 12, 2025 0 101
Jun 24, 2025 0 90
Jun 9, 2025 0 86
Jun 24, 2025 0 82
Jun 9, 2025 0 80